WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹4.95 Cr |
Mar2024 | ₹3.95 Cr |
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4.95 Cr | 25.46 | |
Mar2024 | ₹3.95 Cr | 14.84 | |
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,016.4 Cr | -4% | -9.1% | 10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,626.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,996.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,494.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,718.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,374.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -4% |
-9.1% |
10.1% |
SENSEX | 1.8% |
2.1% |
0.2% |
You may also like the below Video Courses